Characterisation of a novel mouse liver aldo-keto reductase AKR7A5

A. Hinshelwood, G. McGarvie, E. Ellis

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

We have characterised a novel aldo-keto reductase (AKR7A5) from mouse liver that is 78% identical to rat aflatoxin dialdehyde reductase AKR7A1 and 89% identical to human succinic semialdehyde (SSA) reductase AKR7A2. AKR7A5 can reduce 2-carboxybenzaldehyde (2-CBA) and SSA as well as a range of aldehyde and diketone substrates. Western blots show that it is expressed in liver, kidney, testis and brain, and at lower levels in skeletal muscle, spleen heart and lung. The protein is not inducible in the liver by dietary ethoxyquin. Immunodepletion of AKR7A5 from liver extracts shows that it is one of the major liver 2-CBA reductases but that it is not the main SSA reductase in this tissue.
Original languageEnglish
Pages (from-to)213-218
Number of pages6
JournalFEBS Letters
Volume523
Issue number1-3
DOIs
Publication statusPublished - 2002

Keywords

  • aldo-keto reductase
  • carbonyl metabolism
  • succinic semialdehyde
  • mouse liver

Fingerprint Dive into the research topics of 'Characterisation of a novel mouse liver aldo-keto reductase AKR7A5'. Together they form a unique fingerprint.

  • Cite this